Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

On 14 Dec, Mr Gilles Garachon, the French Ambassador to Thailand, arrived at Mae Sot in Thailand to present France’s highest award, l'Ordre National de la Légion d’honneur, to Professor François Nosten, Head of MORU’s Shoklo Malaria Research Unit (SMRU). The award is in recognition of Professsor Nosten's work over three decades fighting malaria.

Composite photo of the celebration of Francois Nosten receiving the Legion d'Honneur

Guests representing many SMRU partners who contributed to this award attended the ceremony including: Eh Ka Lu Shwe Oo from the Karen Department Health and Welfare (KDHW), Dr Cynthia Maung from the Mae Tao Clinic, Maw Ronnatrai, the former director of Mae Sot Hospital, Maw Jirapong Authaisin from the Mae Ra Mat Hospital, and representatives from Thai Public Health departments. Nick White and Nick Day represented MORU and many SMRU colleagues also attended.

The festivities later moved to the SMRU office with three generations of staff attending, and many taking turns to say how they enjoyed working with François over the years.

Please join us in giving your heartiest congratulations to François and the SMRU team for this well-deserved honour.

- With thanks to Dr Rose McGready for text and to Nick Day, Stephane Ribrault, Jordi Landier and Suphak Nosten for photos

Similar stories

Phase II Malaria vaccine trial begins in Thailand

The Mahidol Oxford Tropical Medicine Research Unit (MORU) has begun a Phase II trial to demonstrate that R21/matrix M is well-tolerated and immunogenic when administered with the antimalarial drug combination.

Pilot study detects diverse DNA in ingredients of falsified tablets

A recent multidisciplinary pilot study, originating from LOMWRU and the Medicine Quality Research Group of IDDO and MORU, investigated whether bacterial, plant, fungal and animal DNA in the ingredients and from the environment (eDNA) could be detected from falsified (aka counterfeit) tablets.

Ricardo Aguas awarded Associate Professorship

We are delighted to announce that Ricardo Aguas has been awarded the Associate Professor title, in recognition of his achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.

COPCOV investigators meet, and prepare to submit for publication

On 15-16 Dec, COPCOV investigators from around the world met in Bangkok to review study results and plan next steps. Led by co-PIs Prof Sir Nick White and Dr Will Schilling, and funded by the Wellcome Trust, the MORU-led COPCOV ( Chloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting) is the world’s largest multinational trial of COVID-19 prevention.

Researchers call for antimicrobial resistance surveillance to be improved

The number of studies reporting antimicrobial resistance (AMR) data has increased in Africa, South and South East Asia according to new research in the International Journal of Infectious Diseases.

Are we getting tafenoquine dosing right?

Researchers analysing clinical trial data for the new antimalarial drug tafenoquine find that higher doses are needed to cure reliably vivax malaria infection.